SCHEMBL2967008

SCHEMBL2967008

O=[N+]([O-])c1ccc2[nH]c(-c3ccccc3-c3ncc[nH]3)nc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 10/20 0.57
RAB9A P51151 5/20 0.54
NPC1 O15118 4/20 0.54
MAPT P10636 4/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KDM4E B2RXH2 1/20 0.54
METAP1 P53582 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
MMP2 P08253 2/20 0.51
MMP9 P14780 2/20 0.51
MMP8 P22894 2/20 0.51
HTT P42858 2/20 0.48
PKN1 Q16512 1/20 0.48
PKN2 Q16513 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CASP3 P42574 1/20 0.48
MMP13 P45452 1/20 0.48
SENP8 Q96LD8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13221018 0.92 NPBWR1 (0.68) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL4497810 0.89 NPBWR1 (0.65) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL4487881 0.87 MMP2 (0.66) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL4497816 0.86 NPBWR1 (0.74) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL2250346 0.81 NPBWR1 (0.60) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL3190704 0.80 AMY1A (0.59) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL3202735 0.80 NPBWR1 (0.81) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL10579818 0.80 NPBWR1 (0.55) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL3337243 0.80 NPBWR1 (0.81) NPBWR1RAB9ANPC1MAPTL3MBTL1
SCHEMBL4487886 0.80 NPBWR1 (0.76) NPBWR1RAB9ANPC1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7777051-B2 Asymmetric benzimidazoles and related compounds as potassium channel modulators ICAGEN, INC. (US) 2010-08-17 US disclosed
US-20050038067-A1 Asymmetric benzimidazoles and related compounds as potassium channel modulators ICAGEN, INC. (US) 2005-02-17 US disclosed
WO-2005002503-A2 ASYMMETRIC BENZIMIDAZOLES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS ICAGEN, INC. (US) 2005-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038067-A1 Asymmetric benzimidazoles and related compounds as potassium channel modulators KCNJ2, KCNJ1, KCNJ11 NPBWR1 4235/4885RAB9A 3606/4885NPC1 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.